References
1. Федеральные клинические рекомендации по
диагностике и лечению системных васкулитов.
2013 г.
http://rheumatolog.ru/experts/klinicheskierekomendacii
(дата обращения 23.09.2016 г.).
[Federal clinical recommendations on diagnostics
and treatment of systemic vasculitis. http://
rheumatolog.ru/experts/klinicheskie-rekomendacii.
(Accessed 23.03.2016) (in Russ.).]
2. Hautzel H., Sander O., Heinzel A., Schneider M.,
Müller H. Assessment of large-vessel involvement
in giant cell arteritis with 18F-FDG PET: introducing
an ROC-analysis-based cutoff ratio. J. Nucl.
Med. 2008; 49: 1107–13.
3. Sharma B., Jain S., Suri S., Numano F. Diagnostic
criteria for Takayasu arteritis. Int. J. Cardiol. 1996;
54 (Suppl.): S141–7.
4. Aydin S., Yilmaz N., Akar S., Aksu K., Kamali S.,
Yucel E. et al. Assessment of disease activity and
progression in Takayasu's arteritis with Disease
Extent Index – Takayasu. Rheum. 2010; 49 (10):
1889–93.
5. Sait S., Sabire Y., Meftune C., Metin H., Nurhan E.,
Hediye P. F-18 FDG PET/CT findings of a patient
with Takayasu arteritis before and after therapy. Mol.
Imag. Radionuc. Ther. 2012; 21 (1): 32–4.
6. Bucerius J. Monitoring vasculitis with 18F-FDG
PET. Q. J. Nuc. Med. Mol. Imag. 2016; 60 (3):
219–35.
7. Puppo C., Massollo M., Paparo F., Camellino D.,
Piccardo A., Shoushtari Z. et al. Giant cell arteritis:
a systematic review of the qualitative and semiquantitative
methods to assess vasculitis with 18F-fluorodeoxyglucose
positron emission tomography.
Biomed. Res. Int. 2014; 2014: 574248.
8. Blockmans D., Stroobants S., Maes A., Mortelmans
L. Positron emission tomography in giant cell
arteritis and polymyalgia rheumatica: evidence for
inflammation of the aortic arch. Am. J. Med. 2000;
108: 246–9.
9. Henes J., Mueller M., Pfannenberg C., Kanz L.,
Koetter I. Cyclophosphamide for large vessel vasculitis:
assessment of response by PET/CT. Clin.
Exp. Rheum. 2011; 29 (64): 43–8.
10. Hooisma G., Balink H., Houtman P., Slart R.,
Lensen K. Parameters related to a positive test result
for FDG PET(/CT) for large vessel vasculitis:
a multicenter retrospective study. Clin. Rheum.
2012; 31: 861–71.
11. Boysson H., Liozon E., Lambert M., Parienti J.,
Artigues N., Geffray L. et al. 18F-fluorodeoxyglucose
positron emission tomography and the risk of
subsequent aortic complications in giant-cell arteritis.
Medicine. 2016; 95 (26): e3851. DOI: 10.1097/
MD.0000000000003851.
12. Hooisma G., Balink H., Houtman P., Slart R.,
Lensen K. Parameters related to a positive test
result for FDG PET(/CT) for large vessel vasculitis:
a multicenter retrospective study. Clin. Rheumatol.
2012; 31: 861–71.
13. Bertagna F., Bosio G., Caobelli F., Motta F.,
Biasiotto G., Giubbini R. Role of 18F-fluorodeoxyglucose
positron emission tomography/
computed tomography for therapy evaluation of
patients with large-vessel vasculitis. Jap. J. Radiol.
2010; 28 (3): 199–204.
14. Blockmans D., De Ceuninck L., Vanderschueren
S., Knockaert D., Mortelmans L., Bobbaers H.
Repetitive 18F-fluorodeoxyglucose positron emission
tomography in giant cell arteritis: a prospective
study of 35 patients. Rheumatology. 2007; 46 (4):
672–7.
15. Moosig F., Czech N., Mehl C., Henze E., Zeuner
R., Kneba M. et al. Correlation between 18-fluorodeoxyglucose
accumulation in large vessels and
serological markers of inflammation in polymyalgia
rheumatica: a quantitative PET study. Ann. Rheum.
Dis. 2004; 63: 870–3.
16. Lehmann P., Buchtala S., Achajew N., Haerle P.,
Ehrenstein B., Lighvani H. et al. 18F-FDG PET as
a diagnostic procedure in large vessel vasculitis –
a controlled, blinded rexamination of routine PET
scans. Clin. Rheum. 2011; 30: 37–42.
17. Fuchs M., Briel M., Daikeler T., Walker U.,
Rasch H., Berg S. et al. The impact of 18F-FDG
PET on the management of patients with suspected
large vessel vasculitis. Eur. J. Nuc. Med. Mol.
Imaging. 2012; 39 (2): 344–53.
18. Walter M., Melzer R., Schindler C., Müller-
Brand J., Tyndall A., Nitzsche E. The value of [18F]
FDG-PET in the diagnosis of large-vessel vasculitis
and the assessment of activity and extent of disease.
Eur. J. Nuc. Med. Mol. Imag. 2005; 32 (6):
674–81.
19. Blockmans D., Bley T., Schmidt W. Imaging for
large-vessel vasculitis. Curr. Opin. Rheumatol. 2009;
21: 19–28.
20. Both M., Hmadi-Simab K., Reuter M., Dourvos O.,
Fritzer E., Ullrich S. et al. MRI and FDG-PET
in the assessment of inflammatory aortic arch syndrome
in complicated courses of giant cell arteritis.
Ann. Rheum. Dis. 2008; 67 (7): 1030–3.
21. Villa I., Agudo B., Martinez-Taboada. Achievements
in the diagnosis of a vasculitis of large vessels:
identification of biomarkers and imaging studies.
Clin. Rheum. 2011; 6 (3): 22–7.
22. Kale N., Eggenberger E. Diagnosis and management
of cell arthritis: a review. Curr. Opin. Ophthal.
2010; 21 (6): 417–22.